The anti-viral T cell response is believed to play a central role in the pathogenesis of hepatitis C virus infection. Since chronic evolution occurs in > 50% of HCV infections, the sequential analysis of the T cell response from the early clinical stages of disease may contribute to define the features of the T cell response associated with recovery or chronic viral persistence. For this purpose, 21 subjects with acute hepatitis C virus infection were sequentially followed for an average time of 44 wk. Twelve patients normalized transaminase values that remained normal throughout the follow-up period; all but two cleared hepatitis C virus-RNA from serum. The remaining nine patients showed persistent viremia and elevated transaminases. Analysis of the peripheral blood T cell proliferative response to core, E1, E2, NS3, NS4, and NS5 recombinant antigens and synthetic peptides showed that responses to all hepatitis C virus antigens, except E1, were significantly more vigorous and more frequently detectable in patients who normalized transaminase levels than in those who did not. By sequential evaluation of the T cell response, a difference between the two groups of patients was already detectable at the very early stages of acute infection and then maintained throughout the follow-up period. The results suggest that the vigor of the T cell response during the early stages of infection may be a critical determinant of disease resolution and control of infection.
G Missale, R Bertoni, V Lamonaca, A Valli, M Massari, C Mori, M G Rumi, M Houghton, F Fiaccadori, C Ferrari
Title and authors | Publication | Year |
---|---|---|
DAP12 Deficiency in Liver Allografts Results in Enhanced Donor DC Migration, Augmented Effector T Cell Responses and Abrogation of Transplant Tolerance: DAP12 and Liver Transplant Tolerance
O Yoshida, S Kimura, L Dou, BM Matta, S Yokota, MA Ross, DA Geller, AW Thomson |
American Journal of Transplantation | 2014 |
Protective Immunity Against Hepatitis C: Many Shades of Gray
MS Abdel-Hakeem, NH Shoukry |
Frontiers in immunology | 2014 |
Immune Responses to HCV and Other Hepatitis Viruses
SH Park, B Rehermann |
Immunity | 2014 |
Adaptive immune response during hepatitis C virus infection
JR Larrubia, E Moreno-Cubero, MU Lokhande, S García-Garzón, A Lázaro, J Miquel, C Perna, E Sanz-de-Villalobos |
World journal of gastroenterology : WJG | 2014 |
Innate and adaptive immune responses in HCV infections
MH Heim, R Thimme |
Journal of Hepatology | 2014 |
Acute Hepatitis C: Management in the Rapidly Evolving World of HCV
SA Sharma, JJ Feld |
Current Gastroenterology Reports | 2014 |
Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination
G Ahlén, F Holmström, A Gibbs, M Alheim, L Frelin |
Gene Therapy | 2014 |
Induction of Cell-Mediated Immune Responses in Mice by DNA Vaccines That Express Hepatitis C Virus NS3 Mutants Lacking Serine Protease and NTPase/RNA Helicase Activities
SL Ratnoglik, DP Jiang, C Aoki, P Sudarmono, I Shoji, L Deng, H Hotta, G Ahlenstiel |
PloS one | 2014 |
Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection
PA Knolle, R Thimme |
Gastroenterology | 2014 |
Why is it so difficult to develop a hepatitis C virus preventive vaccine?
C Zingaretti, RD Francesco, S Abrignani |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2014 |
Therapeutic vaccines against hepatitis C virus
J Xue, H Zhu, Z Chen |
Infection, Genetics and Evolution | 2014 |
Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells
S Mishra, PT Losikoff, AA Self, F Terry, MT Ardito, R Tassone, WD Martin, AS de Groot, SH Gregory |
Vaccine | 2014 |
Immune tolerance in liver disease: HEPATOLOGY, Vol. XX, No. X, 2014 CRISPE
IN Crispe |
Hepatology | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Latin American Association for the Study of the Liver Recommendations on Treatment of Hepatitis C
N Méndez-Sánchez, R Paraná, H Cheinquer, AA de Mattos, A Gadano, M Silva, MG Pessôa, ML Gomes-Ferraz, A Soza, MC Mendes-Correa, NC Chávez-Tapia, L Dagher, M Padilla, N Hernandez, JF Sánchez-Avila, F Contreras, HS Moraes-Coelho, ER Parise, F Bessone, M Uribe |
ANN HEPATOL | 2014 |